Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-2395